General
Experience2 yrs
Elite Ratings
--
Practice Areas
Biotech (7 cases)
Reexam/Aband. (1 case)
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:23-CV-00714 | Intercept Pharmaceuticals, Inc. v. Zenara Pharma Private Limited | 06/30/23 | Challenger | |
| 1:23-CV-00039 | Merck KGaA v. Aurobindo Pharma USA Inc | 01/13/23 | Challenger | |
| 1:22-CV-01215 | Intercept Pharmaceuticals, Inc. v. Zenara Pharma Private Limited | 09/16/22 | Challenger | |
| 1:22-CV-00379 | Merck Sharp & Dohme Corp v. Zenara Pharma Pvt Ltd | 03/23/22 | Challenger | |
| 1:22-CV-00378 | PF Prism Imb BV v. Hetero USA Inc | 03/23/22 | Challenger | |
| 1:21-CV-01794 | Novartis Pharma Corp v. Torrent Pharma Inc | 12/22/21 | Challenger | |
| 1:21-CV-01760 | Novartis Pharma Corp v. Hetero USA Inc | 12/16/21 | Challenger | |
| 1:21-CV-01614 | Taro Pharmaceutical Industries v. Encube Ethicals Pvt Ltd | 11/15/21 | Challenger |